Retatrutide is a triple-receptor agonist peptide that targets: GLP-1 (appetite regulation) GIP (metabolic signaling) Glucagon receptor (energy expenditure) This combination makes it a next-generation metabolic therapy currently being studied for weight loss and metabolic optimization
'Supplements are not very well regulated, so you have to rely on what the manufacturer says, and this is not always very reliable
With a suite of new medicines, Roche believes it can still catch up and become a top three player in the obesity market
China has become a hotbed of biopharma innovation, and the metabolic space has been key to recent cross-border deals from Pfizer, AstraZeneca and other drugmakers seeking to follow Novo Nordisk and Eli Lilly
Prevention of diet-induced obesity: healthy, nonobese animals at baseline receiving experimental treatment while receiving a high-fat diet
Use bacteriostatic water (BAC) Contains 0.9% benzyl alcohol for preservation in research solutions